Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Current Leases (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Current Leases for 13 consecutive years, with $976000.0 as the latest value for Q3 2025.

  • Quarterly Current Leases fell 3.17% to $976000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $976000.0 through Sep 2025, down 3.17% year-over-year, with the annual reading at $12000.0 for FY2024, 9.09% up from the prior year.
  • Current Leases for Q3 2025 was $976000.0 at Niagen Bioscience, up from $6000.0 in the prior quarter.
  • The five-year high for Current Leases was $1.0 million in Q3 2024, with the low at $6000.0 in Q2 2025.
  • Average Current Leases over 5 years is $286333.3, with a median of $14500.0 recorded in 2021.
  • The sharpest move saw Current Leases surged 5161.54% in 2022, then crashed 98.94% in 2025.
  • Over 5 years, Current Leases stood at $20000.0 in 2021, then dropped by 20.0% to $16000.0 in 2022, then plummeted by 31.25% to $11000.0 in 2023, then rose by 9.09% to $12000.0 in 2024, then skyrocketed by 8033.33% to $976000.0 in 2025.
  • According to Business Quant data, Current Leases over the past three periods came in at $976000.0, $6000.0, and $9000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.